ArticleBiomedicines2026

HLA Class I and II Variants as Potential Determinants of Clinical Severity and Mortality in Patients with COVID-19: A Prospective Study from Saudi Arabia.

Jawaher A Alsubait et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.